Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates.
Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
RxSight shares jumped 20% to $44.31 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Harpoon Therapeutics, Inc. (NASDAQ: HARP) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash.
- Ambrx Biopharma Inc. (NASDAQ: AMAM) jumped 98.1% to $27.00 after Johnson & Johnson announced it will acquire the company in an all-cash merger for a total equity value of approximately $2 billion.
- Spectaire Holdings Inc. (NASDAQ: SPEC) jumped 75.2% to $2.96.
- Nkarta, Inc. (NASDAQ: NKTX) rose 51% to $9.17 as the company announced updated corporate presentation to reflect business and strategic update.
- Universe Pharmaceuticals INC (NASDAQ: UPC) gained 42% to $2.22.
- Elevation Oncology, Inc. (NASDAQ: ELEV) jumped 39.2% to $1.2193.
- NexImmune, Inc. (NASDAQ: NEXI) rose 34.7% to $8.32.
- Praxis Precision Medicines, Inc. (NASDAQ: PRAX) rose 34% to $33.76 as the company issued update on advancing clinical stage portfolio.
- QuantaSing Group Limited (NASDAQ: QSG) gained 31% to $2.0563.
- Butterfly Network, Inc. (NASDAQ: BFLY) rose 29.7% to $1.31 as the company announced FDA clearance of handheld ultrasound system, Butterfly iQ3.
- Venus Concept Inc. (NASDAQ: VERO) climbed 28% to $1.51.
- Ardelyx, Inc. (NASDAQ: ARDX) gained 25.5% to $7.73 after the company provided an update on its progress in 2023 and initial expectations for 2024.
- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 20.8% to $7.36 after the company issued preliminary Q4 revenue guidance above estimates. Also the company said it is approaching positive EPS and cash flow in 2H 2025.
- Axonics, Inc. (NASDAQ: AXNX) jumped 19.9% to $69.03 after the company announced a deal to be acquired by Boston Scientific.
- Crocs, Inc. (NASDAQ: CROX) jumped 18.8% to $102.69 after the company issued strong Q4 and full year 2023 guidance.
- LendingTree, Inc. (NASDAQ: TREE) rose 17.3% to $33.50.
- Wolverine World Wide, Inc. (NYSE: WWW) jumped 16.7% to $9.02. Wolverine Worldwide affirmed preliminary 2023 financial results in line with guidance.
- Ampio Pharmaceuticals, Inc. (NYSE: AMPE) gained 16.4% to $2.0799 after falling around 8% on Friday.
- Shattuck Labs, Inc. (NASDAQ: STTK) gained 15.2% to $9.52.
- Vincerx Pharma, Inc. (NASDAQ: VINC) shares rose 14.3% to $1.36 after the company announced compelling clinical efficacy of enitociclib in combination with venetoclax and prednisone in lymphoma.
- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) shares gained 14.1% to $2.84 after jumping over 10% on Friday.
- Silk Road Medical, Inc (NASDAQ: SILK) rose 13.4% to $12.91.
- OPKO Health, Inc. (NASDAQ: OPK) jumped 12.5% to $1.00.
- Avadel Pharmaceuticals plc (NASDAQ: AVDL) gained 12% to $16.68 after the company issued a business update.
- Fastly, Inc. (NYSE: FSLY) jumped 10.5% to $17.88 after RBC Capital upgraded the stock from Underperform to Sector Perform and raised its price target from $12 to $18.
- Upwork Inc. (NASDAQ: UPWK) gained 10.3% to $15.51 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $13 to $20.
- Commercial Metals Company (NYSE: CMC) rose 6.2% to $51.21 following strong quarterly results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- LumiraDx Limited (NASDAQ: LMDX) shares fell 45.5% to $0.0187. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th.
- Top KingWin Ltd (NASDAQ: TCJH) dipped 38.8% to $1.18.
- Solo Brands, Inc. (NYSE: DTC) dipped 38.7% to $3.6150 after the company lowered full year 2023 revenue guidance below estimates.
- Dada Nexus Limited (NASDAQ: DADA) shares dipped 38.1% to $1.95. Dada Nexus said in the course of its routine internal audit, certain suspicious practices were identified that may cast doubt on certain revenues from the company's online advertising and marketing services in 2023.
- Prothena Corporation plc (NASDAQ: PRTA) fell 25.1% to $30.45 after the company issued updates on PRX012, PRX123, Birtamimab and Portfolio programs.
- Jin Medical International Ltd. (NASDAQ: ZJYL) fell 23.4% to $95.00.
- MMTec, Inc. (NASDAQ: MTC) fell 22.4% to $1.82.
- Evolve Transition Infrastructure LP (NASDAQ: SNMP) tumbled 20.8% to $1.33.
- Revance Therapeutics, Inc. (NASDAQ: RVNC) fell 20.1% to $6.68 after the company issued preliminary Q4 and FY23 financial results and guidance.
- Banzai International, Inc. (NASDAQ: BNZI) shares fell 19.3% to $2.07. Banzai shares jumped around 55% on Friday after the company signed an LOI to acquire IGLeads.
- Northern Dynasty Minerals Ltd. (NYSE: NAK) dipped 18.8% to $0.3107.
- The Arena Group Holdings, Inc. (NYSE: AREN) shares fell 18.2% to $1.7603 after dipping 17% on Friday.
- The Arena Group Holdings, Inc. (NASDAQ: AREN) dipped 18% to $ 1.7650.
- Inspire Veterinary Partners, Inc. (NASDAQ: IVP) declined 16.8% to $0.1881. Inspire Veterinary Partners recently filed a prospectus related to up to a $5 million public offering
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) fell 15.1% to $7.99. Pacific Biosciences of California said it sees preliminary FY23 revenue of $200.5 million.
- REGENXBIO Inc. (NASDAQ: RGNX) fell 14.8% to $14.01. US District Court issued decision on REGENXBIO and University of Pennsylvania NAV technology patent infringement lawsuit.
- Revance Therapeutics, Inc. (NASDAQ: RVNC) fell 13.6% to $7.21. Revance issued corporate update, preliminary Q4 and FY23 financial results, and financial outlook.
- BioSig Technologies, Inc. (NASDAQ: BSGM) fell 13.6% to $0.35. On Jan. 5, BioSig Technologies received a letter from Nasdaq notifying company has regained compliance with Nasdaq Listing Rule 5550(b)(2).
- Bright Health Group, Inc. (NYSE: BHG) dipped 12.8% to $10.00.
- Safe and Green Development Corporation (NASDAQ: SGD) shares fell 11.3% to $1.80 after jumping 49% on Friday.
- Argo Blockchain plc (NASDAQ: ARBK) fell 11.1% to $3.11 after announcing £7.8 million ($9.9 million) placing.
- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) dipped 10.7% to $0.5146. Shuttle Pharmaceuticals received FDA approval to proceed with Phase II clinical trial of ropidoxuridine for the treatment of patients with glioblastoma.
- Paragon 28, Inc. (NYSE: FNA) fell 9.6% to $11.83. Paragon 28 said it sees preliminary fourth-quarter revenue of $60.3 million to $60.6 million.
- Sharps Technology, Inc. (NASDAQ: STSS) fell 8.3% to $0.4032 after jumping 12% on Friday.
- Dynavax Technologies Corporation (NASDAQ: DVAX) dipped 7.5% to $13.63. Dynavax sees preliminary 2023 HEPLISAV-B vaccine net product revenue of $213 million.
- The Boeing Company (NYSE: BA) fell 7% to $231.69 after an exit door blew out of a 737 aircraft during a commercial flight.
- Spirit AeroSystems Holdings, Inc. (NYSE: SPR) fell 6.5% to $29.67 after an exit door blew out of a 737 aircraft during a commercial flight. Spirit Aerosystems was a vendor involved with the faulty door.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things'
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.